CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 1,024 enrolled
Drug / intervention
Intervention Condition +1 morebehavioral
Likely dose
Not stated in record
Key inclusion· 3
  • Self-reported injection drug use within the prior 6 months
  • Willingness to invite a risk network member and discuss HIV prevention
  • Age 18 or older
Key exclusion· 1
  • Currently enrolled in another HIV prevention intervention

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00218335
NCT00218335Phase 2Completed

A Network & Dyad HIV Prevention Intervention for IDU's

Johns Hopkins Bloomberg School of Public Health·interventional·Posted Sep 22, 2005·Updated Apr 18, 2013

In Brief

A Phase 2 clinical trial evaluating Intervention Condition and Control Condition for HIV and Hepatitis. Completed, enrolled 1,024 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV, Hepatitis
CountriesUnited States

Timeline

Phase 2CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2005
Enrollment StartJun 1, 2003
Primary CompletionMay 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 20.8 years ago

Interventions

Intervention Conditionbehavioral

In the intervention Condition participants were trained to be Health Educators. The intervention focused on HIV risk reduction by teaching knowledge and skills to reduce injection, drug splitting, and sex risk, and by teaching communication skills to conduct outreach to personal risk network members. The intervention consisted of five group-based sessions, one individual session, and one dyad session with a risk network member.

Control Conditionbehavioral

The control condition focused on injection drug-use related topics (e.g. HIV testing, Hepatitis C and drug overdose). The sessions were educational and did not include skills training. The control condition consisted of five group-based sessions.